HER2 has a key role in signal transduction and oncogenesis; in particular, HER2 aberrations, including both amplification and mutations, have been considered as oncogenic drivers that contribute to 2% to 6% of lung adenocarcinoma. The gene discussed is ERBB2; the disease is lung adenocarcinoma.